malignant peripheral nerve sheath tumors

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Wilms Tumor, Rhabdoid Tumor, Malignant Peripheral Nerve Sheath Tumors Trial in United States (Selinexor)

Recruiting
  • Wilms Tumor
  • +6 more
  • Los Angeles, California
  • +10 more
Aug 2, 2023

Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jun 30, 2022

Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • second generation 4-1BBζ EGFR806-EGFRt
  • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
  • Seattle, Washington
    Seattle Children's Hospital
May 2, 2022

Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1 Trial in United States (Selumetinib, Sirolimus)

Active, not recruiting
  • Malignant Peripheral Nerve Sheath Tumors
  • Neurofibromatosis 1
  • Washington, District of Columbia
  • +4 more
Apr 1, 2022

Sarcoma, Malignant Peripheral Nerve Sheath Tumors Trial in United States (PLX3397, Sirolimus)

Recruiting
  • Sarcoma
  • Malignant Peripheral Nerve Sheath Tumors
  • Iowa City, Iowa
  • +4 more
Aug 26, 2021

Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)

Active, not recruiting
  • Sarcoma
  • +10 more
  • Hypofractionated radiotherapy
  • Hyperthermia
  • Warsaw, Mazovian, Poland
    Maria Sklodowska-Curie Institute - Oncology Center
Jan 27, 2021

Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)

Unknown status
  • Sarcoma
  • +16 more
  • Sequential chemotherapy - 3 courses of AI
  • Hypofractionated radiotherapy
  • Warsaw, Mazovian, Poland
    Maria Sklodowska-Curie Institute - Oncology Center
Jan 19, 2021

Liposarcoma, Malignant Peripheral Nerve Sheath Tumors, Alveolar Soft Part Sarcoma Trial in New York (Selinexor, Ixazomib)

Withdrawn
  • Liposarcoma
  • +4 more
  • New York, New York
    Columbia University Medical Center
Nov 24, 2020

Malignant Peripheral Nerve Sheath Tumors, MPNST, Sarcoma Trial in United States (everolimus, bevacizumab)

Completed
  • Malignant Peripheral Nerve Sheath Tumors
  • +2 more
  • Birmingham, Alabama
  • +11 more
Feb 13, 2019

Malignant Peripheral Nerve Sheath Tumors Trial in Berlin, Hamburg (imatinib mesylate)

Terminated
  • Malignant Peripheral Nerve Sheath Tumors
  • imatinib mesylate
  • Berlin, Germany
  • +1 more
Aug 6, 2012